Subscribe to nfx bio
NFX Bio Insights delivered weekly to your inbox
Companies
We join forces with rare individuals who make the whole of our network greater than the sum of its parts. We refuse to think of our founders as a “portfolio” – instead, we’re cultivating a Guild.
Twist Bioscience Corp.
Synthetic Biology
NASDAQ – TWST
Genome Compiler
Market-Network for synthetic biology industry
Acquired by Twist Bioscience
Mammoth Biosciences
The CRISPR data platform
for diagnostics
Co-Investors – Mayfield, 8VC, Danhua Capital, Decheng Capital
C2i Genomics
Bio platform for monitoring treatment response for various types of solid cancer
light-bio
Novel capabilities in bioluminescence through synthetic biology
Nano Carry
Technology platform for safe/effective delivery of biologics to the brain
Wild Biotech
Therapeutics company treating the incurable
EdiTy Therapeutics
Novel delivery platform for in-vivo gene editing
Eleven Therapeutics
Exploring programmable therapies
Gilboa Therapeutics
Gilboa Therapeutics develops a novel cell therapy for solid cancers
See other non-bio NFX Companies
La Jolla Labs
Technology for RNA-targeting and mRNA therapeutics
Mana.Bio
Programmable Drug Delivery
Pangea Biomed
Transcriptomics and Synthetic Lethality-based I/O therapy Platform
Pepper Bio
Technology for RNA-Targeting & mRNA Therapeutics
Psyga
Psychedelic Plant-Based Medicine
Trojan
Developing the Next Generation of Therapeutic Antibodies
Talus
Gene regulator profiling in live cells for drug development
NFX Bio Content
To see the full library of Bio-related content, click here.
